These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 449970)

  • 1. Quantitative assay of hepatitis B surface antigen and DNA polymerase activity.
    Heijtink RA; Schalm SW
    N Engl J Med; 1979 Jul; 301(3):165. PubMed ID: 449970
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological markers of hepatitis B infection.
    Burrell CJ
    Clin Gastroenterol; 1980 Jan; 9(1):47-63. PubMed ID: 6994952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of serum DNA polymerase activities in hepatitis B carriers.
    Chin Med J (Engl); 1980 Mar; 93(3):173-6. PubMed ID: 6766848
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of hepatitis B surface antigen (HBsAg) in patients with pulmonary tuberculosis].
    Fondaminskaia LD
    Probl Tuberk; 1986; (3):25-7. PubMed ID: 3714688
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
    Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
    Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics examination of eliminating surface antigen of Hepatitis B Virus (HBsAg) and its significance for the prognosis of the disease and the carrier state (author's transl)].
    Pejcochová J; Jandásek L; Jezek P; Horecká J
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):79-83. PubMed ID: 149606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Viral hepatitis B and the antigen carrier state in tuberculosis patients].
    Vil'derman AM; Marchenko IuG; Gul'pe PA; Mel'nichuk AE; Shtefanaru LK
    Probl Tuberk; 1981 Jun; (6):43-7. PubMed ID: 7279909
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidental detection of hepatitis B surface antigen: a growing concern for the Indian physician.
    Acharya SK
    Trop Gastroenterol; 2002; 23(2):47-8. PubMed ID: 12632965
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of clinical biochemical indices of the state of the liver in prolonged HBs-antigenemia].
    Khersonskaia RIa; Gromashevskaia LL; Rogotskaia LT; Shkurova OS
    Vrach Delo; 1979 Jun; (6):114-7. PubMed ID: 473711
    [No Abstract]   [Full Text] [Related]  

  • 11. HBV-associated DNA polymerase activity in plasmas from HBsAg carriers in Taiwan.--A preliminary report.
    Lai LW; Hsu LC; Liu WT; Chen DS; Chen JY; Yang CS
    Taiwan Yi Xue Hui Za Zhi; 1982 Aug; 81(8):1023-6. PubMed ID: 6960130
    [No Abstract]   [Full Text] [Related]  

  • 12. [Markers of type B viral hepatitis].
    Brunello F; Emanuelli G; Camussi G
    Minerva Med; 1979 Sep; 70(41):2791-800. PubMed ID: 386166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific serological diagnosis of viral hepatitis.
    Zuckerman AJ
    Br Med J; 1979 Jul; 2(6182):84-6. PubMed ID: 466328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies of the so-called asymptomatic carriers of surface antigen HBsAg of hepatitis B virus].
    Urbański S; Kowalewski R
    Wiad Lek; 1979 Feb; 32(3):141-4. PubMed ID: 442638
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of the Australia antigen carrier state].
    Mel'nik GV
    Klin Med (Mosk); 1982 Jan; 60(1):34-7. PubMed ID: 7078035
    [No Abstract]   [Full Text] [Related]  

  • 16. A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease.
    Rizzetto M; Shih JW; Verme G; Gerin JL
    Gastroenterology; 1981 Jun; 80(6):1420-7. PubMed ID: 7014350
    [No Abstract]   [Full Text] [Related]  

  • 17. Type B hepatitis: virology, serology and clinical course.
    Hoofnagle JH
    Semin Liver Dis; 1981 Feb; 1(1):7-14. PubMed ID: 7051294
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunology of the hepatitis viruses.
    Barker LF; Gerety RJ; Tabor E
    Adv Intern Med; 1978; 23():327-51. PubMed ID: 204170
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of hepatitis B by Dane particle associated DNA polymerase assay.
    Cappel R; De Cuyper F; Van Beers D
    J Med Virol; 1978; 3(1):77-80. PubMed ID: 731223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies in the therapy of hepatitis B surface antigen (HBsAg-)-positive chronic hepatitis].
    Hess G; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1933-7. PubMed ID: 2430769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.